Lv6
1750 积分 2024-09-23 加入
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
7小时前
已完结
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
7小时前
已完结
Approaching a therapeutic inflection point for FLT3-mutated AML
9小时前
已完结
Targeting FLT3 for treating diseases: FLT3 inhibitors
9小时前
已完结
Biomarkers as Surrogate Endpoints in Drug Development: Finding Their Right Place
10天前
已完结
Acute myeloid leukaemia
2个月前
已完结
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
3个月前
已完结
Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study
3个月前
已完结
Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study
3个月前
已完结
Targeting Neutrophilic Inflammation in Obstructive Airway Disease - A Narrative Review of Brensocatib Therapy
4个月前
已关闭
皖公网安备34019202002308
